Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $36.4600 (-1.19%) ($36.2600 - $36.4600) on Wed. Jul. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.69% (three month average) | RSI | 64 | Latest Price | $36.4600(-1.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.3% a day on average for past five trading days. | Weekly Trend | HALO advances 2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) BNDX(32%) IBB(29%) CEMB(28%) IWO(26%) IFRA(25%) | Factors Impacting HALO price | HALO will decline at least -1.345% in a week (0% probabilities). TBT(-21%) INDA(-18%) UUP(-15%) IGOV(-15%) EDOC(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.345% (StdDev 2.69%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $35.7(2.13%) | 10 Day Moving Average | $35.37(3.08%) | 20 Day Moving Average | $34.82(4.71%) | To recent high | -4.9% | To recent low | 20.9% | Market Cap | $4.983b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |